02:05 PM EDT, 03/24/2026 (MT Newswires) -- CVS Health ( CVS ) has reached a proposed settlement with the Federal Trade Commission over insulin pricing, Reuters reported Tuesday, citing the company.

The company's pharmacy benefit management unit, Caremark, has focused on lowering prescription drug costs, CVS said, adding that the settlement is expected to be finalized in the coming weeks, with final terms still pending, according to the report.

CVS Health ( CVS ) and the FTC didn't immediately reply to MT Newswires' request for comments.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 72.06, Change: +0.77, Percent Change: +1.08